Atlas Trials

Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg

Clinical trial NCT00649532 · COMPLETED

Trial details

NCT number
NCT00649532
Sponsor
Mylan Pharmaceuticals Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2003-07-01
Primary completion
2003-07-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.